Resistant hyperthyroidism induced by sodium iopodate used as treatment for Graves' disease.
Sodium iopodate has recently been advocated for long-term control of hyperthyroidism in Graves' disease. Its advantages over conventional therapy are a rapid fall in thyroid hormones and control of symptoms with a simple dosage regime. We report a case in which severe resistant hyperthyroidism developed during treatment of Graves' disease with sodium iopodate. Sodium iopodate may not be suitable for long-term use in all patients with Graves' disease.
Caldwell
G
G
Department of Medicine, Royal Postgraduate Medical School, London, UK.
Errington
M
M
Toft
A D
AD
D000328:Adult; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced*; D007487:Ipodate / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors
D007487:Ipodate